Evidence map›Paper›PMID 33268439›Full record

ArticleEuropean respiratory review : an official journal of the European Respiratory Society2020

Current developments and future directions in COPD.

Alexander G Mathioudakis, Lowie E G W Vanfleteren, Lies Lahousse, Andrew Higham, James P Allinson, Carolina Gotera, Dina Visca, Dave Singh, Antonio Spanevello

Abstract read
In one paragraph

Article in European respiratory review : an official journal of the European Respiratory Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2023
    Pooled it
  3. Article
  4. Observational
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Point-of-Care Monitoring of Respiratory Diseases Using Lateral Flow Assay and CMOS Camera Reader.IEEE journal of translational engineering in health and medicine · 2022
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alexander G MathioudakisDivision of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK alexander.mathioudakis@Manchester.ac.uk.ORCID https://orcid.org/0000-0002-4675-9616
Lowie E G W VanfleterenCOPD Center, Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.ORCID https://orcid.org/0000-0002-4387-4096
Lies LahousseDept of Bioanalysis, Pharmaceutical Care Unit, Ghent University, Ghent, Belgium.ORCID https://orcid.org/0000-0002-3494-4363
Andrew HighamDivision of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK.ORCID https://orcid.org/0000-0002-8094-3505
James P AllinsonThe Royal Brompton Hospital and The National Heart and Lung Institute, Imperial College London, London, UK.
Carolina GoteraDept of Pneumology, IIS-Fundación Jiménez Díaz, ISCIII-CIBERES, Madrid, Spain.
Dina ViscaDivision of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy.ORCID https://orcid.org/0000-0003-2298-1623
Dave SinghDivision of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK.
Antonio SpanevelloDivision of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The European Respiratory Society journals publish respiratory research and policy documents of the highest quality, offering a platform for the exchange and promotion of scientific knowledge. In this article, focusing on COPD, the third leading cause of death globally, we summarise novel research highlights focusing on the disease's underlying mechanisms, epidemiology and management, with the aim to inform and inspire respiratory clinicians and researchers.

Indexed as

Pulmonary Disease, Chronic ObstructiveHumans

Identifiers

PMID33268439
PMCPMC9488623

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.